While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

Merck (MRK) stock sank like a stone on Tuesday after the pharmaceutical giant posted poor guidance for the rest of the year.

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

For patients with HPV16-positive CIN3, vaccination with a replication-incompetent Semliki Forest virus vaccine encoding HPV16 E6 and E7 is safe and shows clinical effectiveness.

Robert F. Kennedy Jr. repeatedly asked to see "data" or "science" showing vaccines are safe — but when an influential Republican senator did so, he dismissed it.

Follow live updates and news coverage of the Senate confirmation hearing for RFK Jr. Stay up to date with real-time developments on key moments and outcomes for Trump’s nominee for health secretary.

India plans to roll out the HPV vaccine in the national immunization programme for school girls to protect them from cervical cancer “in a few months” time, top health ministry officials said Tuesday.

KASIE HUNT: Over the summer you said, “There’s no vaccine that’s safe and effective”. Do you still believe that? RFK JR: “I never said that.” KASIE HUNT: “Play the clip.” RFK JR (clip): “There’s no ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...